RU2004119893A - MEDICINE OF GASTROPEK FOR TREATMENT AND PREVENTION OF DISORDERS OF THE DIGESTION PROCESSES AND METHOD OF ITS APPLICATION - Google Patents

MEDICINE OF GASTROPEK FOR TREATMENT AND PREVENTION OF DISORDERS OF THE DIGESTION PROCESSES AND METHOD OF ITS APPLICATION Download PDF

Info

Publication number
RU2004119893A
RU2004119893A RU2004119893/15A RU2004119893A RU2004119893A RU 2004119893 A RU2004119893 A RU 2004119893A RU 2004119893/15 A RU2004119893/15 A RU 2004119893/15A RU 2004119893 A RU2004119893 A RU 2004119893A RU 2004119893 A RU2004119893 A RU 2004119893A
Authority
RU
Russia
Prior art keywords
gastropec
drug
treatment
prevention
disorders
Prior art date
Application number
RU2004119893/15A
Other languages
Russian (ru)
Other versions
RU2276974C2 (en
Inventor
Галина Борисовна Бравова (RU)
Галина Борисовна Бравова
Эмили Александровна Шишкова (RU)
Эмилия Александровна Шишкова
Тать на Евгеньевна Смирнова (RU)
Татьяна Евгеньевна Смирнова
Валентина Валерьевна Бурмистрова (RU)
Валентина Валерьевна Бурмистрова
Елена Антоновна Нестеренко (RU)
Елена Антоновна Нестеренко
Ольга Александровна Полетаева (RU)
Ольга Александровна Полетаева
Original Assignee
Некоммерческое партнерство Научно-технический центр "Лекарства и биотехнологи " (НТЦ "Лекбиотех") (RU)
Некоммерческое партнерство Научно-технический центр "Лекарства и биотехнология" (НТЦ "Лекбиотех")
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Некоммерческое партнерство Научно-технический центр "Лекарства и биотехнологи " (НТЦ "Лекбиотех") (RU), Некоммерческое партнерство Научно-технический центр "Лекарства и биотехнология" (НТЦ "Лекбиотех") filed Critical Некоммерческое партнерство Научно-технический центр "Лекарства и биотехнологи " (НТЦ "Лекбиотех") (RU)
Priority to RU2004119893/15A priority Critical patent/RU2276974C2/en
Publication of RU2004119893A publication Critical patent/RU2004119893A/en
Application granted granted Critical
Publication of RU2276974C2 publication Critical patent/RU2276974C2/en

Links

Claims (8)

1. Лекарственное средство Гастропек для лечения и профилактики заболеваний, связанных с нарушениями процессов пищеварения, содержащее смесь ферментов и вспомогательных веществ, представляющее собой таблетку, покрытую кишечно-растворимой оболочкой, и способ его применения, отличающееся тем, что в качестве одного из ферментов оно содержит пектатлиазу, входящую в субстанцию Гастролиазы.1. The drug Gastropec for the treatment and prevention of diseases associated with digestive disorders, containing a mixture of enzymes and excipients, which is a tablet coated with an enteric-soluble membrane, and a method for using it, characterized in that it contains one of the enzymes pectatliase, which is part of the substance of gastroliase. 2. Лекарственное средство Гастропек по п.1, отличающееся тем, что пектатлиаза выделена из культуральной жидкости бактериального продуцента Bacillus macerans BS-04 и способна мацерировать пектин и протопектин растительной пищи, способствуя ее перевариванию и усвоению.2. The drug Gastropec according to claim 1, characterized in that pectatliase is isolated from the culture fluid of the bacterial producer Bacillus macerans BS-04 and is able to macerate pectin and protopectin of plant foods, facilitating its digestion and assimilation. 3. Лекарственное средство Гастропек по пп.1 и 2, отличающееся тем, что пектатлиаза стабильна в зоне рН 6,5-8,5, проявляет оптимальную специфическую активность в зоне рН 7,5-8,2 при температуре 35-40°С, имеет молекулярную массу 41000Д-42500Д, изоэлектрическую точку - р1 9,8 и активируется ионами кальция.3. The drug Gastropec according to claims 1 and 2, characterized in that pectatliase is stable in the pH zone of 6.5-8.5, exhibits optimal specific activity in the pH zone of 7.5-8.2 at a temperature of 35-40 ° C has a molecular weight of 41000D-42500D, the isoelectric point is p1 9.8 and is activated by calcium ions. 4. Лекарственное средство Гастропек по пп.1-3, отличающееся тем, что одна таблетка Гастропека содержит пектатлиазной активности не менее 70000 ед.4. The drug Gastropec according to claims 1-3, characterized in that one tablet of Gastropec contains at least 70,000 units of pectatliase activity. 5. Лекарственное средство Гастропек по п.1, отличающееся тем, что дополнительно включает ферменты с протеолитической, амилолитической и липолитической активностью, входящие в субстанцию Панкреатина.5. The drug Gastropec according to claim 1, characterized in that it further includes enzymes with proteolytic, amylolytic and lipolytic activity, which are included in the substance of Pancreatin. 6. Лекарственное средство Гастропек по п.5, отличающееся тем, что одна таблетка Гастропека содержит протеолитической активности не менее 36 ед.6. The drug Gastropec according to claim 5, characterized in that one tablet of Gastropec contains a proteolytic activity of at least 36 units. 7. Способ лечения и профилактики заболеваний человека, связанных с нарушениями процессов пищеварения, отличающийся тем, что в качестве лекарственного средства используют Гастропек, заявленного в пп.1-6.7. A method for the treatment and prevention of human diseases associated with disorders of the digestive process, characterized in that Gastropek as claimed in claims 1-6 is used as a medicine. 8. Способ лечения и профилактики заболеваний человека, связанных с нарушениями процессов пищеварения по п.7, отличающийся тем, что прием лекарственного средства Гастропек осуществляется непосредственно перед или во время еды по 1-2 таблетки 3 раза в день не разжевывая, длительность лечения устанавливается по показаниям.8. The method of treatment and prevention of human diseases associated with disorders of the digestive process according to claim 7, characterized in that the drug Gastropec is taken immediately before or during meals, 1-2 tablets 3 times a day without chewing, the duration of treatment is set according to indications.
RU2004119893/15A 2004-07-01 2004-07-01 Medicinal agent "gastropek" for improving digestion process and method for its using RU2276974C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2004119893/15A RU2276974C2 (en) 2004-07-01 2004-07-01 Medicinal agent "gastropek" for improving digestion process and method for its using

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2004119893/15A RU2276974C2 (en) 2004-07-01 2004-07-01 Medicinal agent "gastropek" for improving digestion process and method for its using

Publications (2)

Publication Number Publication Date
RU2004119893A true RU2004119893A (en) 2006-01-10
RU2276974C2 RU2276974C2 (en) 2006-05-27

Family

ID=35871823

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2004119893/15A RU2276974C2 (en) 2004-07-01 2004-07-01 Medicinal agent "gastropek" for improving digestion process and method for its using

Country Status (1)

Country Link
RU (1) RU2276974C2 (en)

Also Published As

Publication number Publication date
RU2276974C2 (en) 2006-05-27

Similar Documents

Publication Publication Date Title
CN101068565B (en) Compositions containing lipase, protease and amylase for treating pancreatic insufficiency
NO20014507L (en) Medication for the treatment of diabetes
JP2023011830A (en) Control of cellular redox levels
Fitzgerald et al. Potential of a renin inhibitory peptide from the red seaweed Palmaria palmata as a functional food ingredient following confirmation and characterization of a hypotensive effect in spontaneously hypertensive rats
US6051220A (en) Composition to improve digestibility and utilization of nutrients
PT1740197E (en) Prolyl endopeptidease (pep) and glutamine endoprotease for the treatment of celiac sprue
JP2008545774A5 (en)
US20180064769A1 (en) Control of Cellular Redox Levels
JP2012516289A (en) Pharmaceutical preparation
Bagchi et al. Nutrition and Functional Foods in Boosting Digestion, Metabolism and Immune Health
SE454566B (en) PHARMACEUTICAL COMPOSITION CONTAINING AN ACTIVE AMOUNT OF WATER-SOLUBLE PROTEINASES EXTRACTED FROM A WATER-LIVING ANIMAL SELECTED BY THE EUPHAUSIACEAE OR GENERAL MALLOTUS
RU2287335C1 (en) Preparation "bacstitatin" for treating diseases of gastrointestinal tract
RU2004119893A (en) MEDICINE OF GASTROPEK FOR TREATMENT AND PREVENTION OF DISORDERS OF THE DIGESTION PROCESSES AND METHOD OF ITS APPLICATION
Mansurah et al. Partial-purification and characterization of Angiotensin Converting Enzyme inhibitory proteins from the leaves and seeds of Moringa oleifera
JP2015154773A (en) Enzymatic production method for brain-function-improving peptide
RU2396968C2 (en) Agent for treating gastrointestinal disturbances and method for making thereof
CHENG et al. A study of in vivo antihypertensive properties of enzymatic hydrolysate from chicken leg bone protein
JP2010024165A (en) Krill protein-derived angiotensin converting enzyme inhibitor
JP7002212B2 (en) A method for producing a fatigue recovery composition and a pressure enzyme decomposition product for fatigue recovery.
NO20060095L (en) Cells used as carriers for bacteria
Ihse et al. Pancreatic enzymic activities of commercial pancreatic enzyme preparations incubated in human small intestinal juice
CN109486888A (en) A method of extracting multifunction activity peptide from loach
Sizer Medical applications of microbial enzymes
RU2068698C1 (en) Medicinal agent for treatment of patients with decreased externally secretory pancreas function
US11458178B2 (en) Method for alleviating fatigue

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20090702

NF4A Reinstatement of patent

Effective date: 20120420

MM4A The patent is invalid due to non-payment of fees

Effective date: 20130702